Drug discovery is an eternal challenge for the biomedical sciences
Author:
Affiliation:
1. Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States
2. School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
Publisher
Compuscript, Ltd.
Link
https://scienceopen.com/document_file/eeb8c85e-61c5-43c4-bf2e-c07d941cde08/ScienceOpen/amm20221001.pdf
Reference39 articles.
1. Inhibition of the Abl Protein-Tyrosine Kinase In Vitro and In Vivo by a 2-Phenylaminopyrimidine Derivative;E Buchdunger;Cancer Research,1996
2. Natural Products-Prompted Chemical Biology: Phenotypic Screening and a New Platform for Target Identification;H Kakeya;Natural Product Reports,2016
3. Artemisinin, a Miracle of Traditional Chinese Medicine;LY Kong;Natural Product Reports,2015
4. The Re-Emergence of Natural Products for Drug Discovery in the Genomics Era;AL Harvey;Nature Reviews Drug Discovery,2015
5. Applications of Cryo-EM in Small Molecule and Biologics Drug Design;JA Lees;Biochemical Society Transactions,2021
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel sulfonyl-substituted tetrandrine derivatives for colon cancer treatment by inducing mitochondrial apoptosis and inhibiting PI3K/AKT/mTOR pathway;Bioorganic Chemistry;2024-02
2. Development of chalcone-like derivatives and their biological and mechanistic investigations as novel influenza nuclear export inhibitors;European Journal of Medicinal Chemistry;2023-12
3. Identification of the Imidazo[1,2-a]pyrazine Derivative A4 as a Potential Influenza Virus Nucleoprotein Inhibitor;ACS Pharmacology & Translational Science;2023-11-17
4. Sustainable Use of Nanotechnology in Biomedical Sciences;Cutting-Edge Applications of Nanomaterials in Biomedical Sciences;2023-11-03
5. Arf6 as a therapeutic target: Structure, mechanism, and inhibitors;Acta Pharmaceutica Sinica B;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3